The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.
SMJ // Article
Editorial
Neutrophils and Myocardial Injury: Cause or Effect—That is the Question!
Abstract
Inflammation is increasingly being associated with the pathogenesis of coronary heart disease (CHD).1 It is therefore not unusual to assume that leukocytosis is an acute phase reactant during acute myocardial infarction (AMI). This association between leukocytosis and AMI was made nearly five decades ago.2 Since that time, numerous studies have been conducted and there is enough evidence to suggest that AMI is, in fact, a thromboinflammatory state.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115–126.
2. Cole D, Singian E, Katz L. The long-term prognosis following myocardial infarction, and some factors which affect it. Circulation 1954;9:321–334.
3. O’Connell JB. The economic burden of heart failure. Clin Cardiol 2000; 23:III-6–III-10.
4. Forman MB, Virmani R, Puett DW. Mechanisms and therapy of myocardial reperfusion injury. Circulation 1990;81:IV-69–IV-78.
5. Duilio C, Ambrosio G, Kuppusamy P, et al. Neutrophils are primary source of 02 radicals during reperfusion after prolonged myocardial ischemia. Am J Heart Circ Physiol 2001;280:H2649–H2657.
6. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 2004;61:481–497.
7. Rashidi F, Rashidi A, Golmohamadi A, et al. Does absolute neutrophilia predict early congestive heart failure after acute myocardial infarction? A cross-sectional study. South Med J 2008;101:19–23.
8. Kyne L, Hausdorff JM, Knight E, et al. Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J 2000;139:94–100.
9. Foody JM, Farrell MH, Krumholz HM. Beta-blocker therapy in heart failure: scientific review. JAMA 2002;287:883–889.
10. Ross AM, Gibbons RJ, Stone GW, et al. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 2005;45:1775–1780.
11. Théroux P, Chaitman BR, Danchin N, et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations: main results of the GUARDIAN trial: Guard During Ischemia Against Necrosis (GUARDIAN) Investigators. Circulation 2000;102:3032–3038.
12. Ma X-L, Tsao PS, Lefer AM. Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest 1991;88:1237–1243.
13. Grzybowski M, et al. The association between white blood cell count and acute myocardial infarction in-hospital mortality: findings from the National Registry of Myocardial Infarction. Acad Emerg Med 2004;11:1049–1060.
14. Barron HV, Harr SD, Radford MJ, et al. The association between white blood cell count and acute myocardial infarction mortality in patients > or =65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol 2001;38:1654–1661.
15. Bodenheimer T. High and rising health care costs: part 3: the role of health care providers. Ann Intern Med 2005;142:996–1002.
